Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0033774 (
pruritus
)
14,546
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Many
itch
mediators activate GPCR and trigger
itch
via activation of GPCR-mediated signaling pathways. GPCRs are desensitized by GPCR kinases (GRKs). The aim of this study is to explore the role of GRKs in
itch
response and the link between GRKs and glutamine, an amino acid previously shown to be an
itch
reliever.
Itch
responses were evoked by histamine, chloroquine, and dinitrochlorobenzene-induced contact dermatitis (CD). Phosphorylation and protein expression were detected by immunofluorescent staining and Western blotting.
GRK2
knockdown using small interfering RNA enhanced
itch
responses evoked by histamine, chloroquine, and dinitrochlorobenzene-induced CD, whereas
GRK2
overexpression using
GRK2
-expressing adenovirus reduced the
itch
responses. Glutamine reduced all
itch
evoked by histamine, chloroquine, and dinitrochlorobenzene-induced CD. Glutamine-mediated inhibition of
itch
was abolished by
GRK2
knockdown. Glutamine application resulted in a rapid and strong expression of
GRK2
in not only dinitrochlorobenzene-induced CD (within 10 minutes) but also cultured rat dorsal root ganglion cells, F11 (within 1 minute). ERK inhibitor abrogates glutamine-mediated
GRK2
expression and inhibition of
itch
in dinitrochlorobenzene-induced CD. Our data indicate that
GRK2
is a key negative regulator of
itch
and that glutamine attenuates
itch
via a rapid induction of
GRK2
in an ERK-dependent way.
...
PMID:GPCR Kinase (GRK)-2 Is a Key Negative Regulator of Itch: l-Glutamine Attenuates Itch via a Rapid Induction of GRK2 in an ERK-Dependent Way. 2953 May 36